This year’s Christmas party was more than just a festive celebration. It was a beautiful reminder of the power of teamwork and the diversity that makes our company truly unique. Bringing everyone together to create something special was the perfect way to wrap up the year. Every detail was a shared effort from the first idea to the final toast. We took the time to prepare food together, with each dish reflecting the rich cultures and traditions of the many countries our team members come from. The result? A table full of flavours that told stories of where we’ve been and who we are, a celebration of our internationality and shared connection. And of course, the night wouldn’t have been complete without some unforgettable moments at the karaoke stage! Here’s to the magic of working together, whether it’s for a project or a party, and to the shared experiences that make us stronger as a team. #Teamwork #Companyparty
Info
Cell therapy has transformed cancer treatment, yet the hurdles of manufacturing patient-derived cell therapies remain a formidable challenge for the industry. Quality and scalability problems lead to high therapeutic costs and limit access to those life-saving treatments. By harnessing the power of cutting-edge semiconductor technologies, including silicon photonics seamlessly integrated into microfluidic cartridges, Sarcura is orchestrating a transformative shift. Central to Sarcura's mission is the creation of fully automated manufacturing systems endowed with real-time process and product control. This pioneering platform promises to usher in a new era of cost-effective and secure cell therapies, democratizing access to these critical treatments. We aim for a 100x production boost and 10x cost reduction, driving the industrialization of cell therapy manufacturing. Delve deeper at www.sarcura.com, where the future of cancer treatment is being reshaped.
- Website
-
http://www.sarcura.com
Externer Link zu Sarcura
- Branche
- Biotechnologie
- Größe
- 11–50 Beschäftigte
- Hauptsitz
- Klosterneuburg
- Art
- Privatunternehmen
- Gegründet
- 2019
Orte
-
Primär
Wegbeschreibung
Plöcking 2
IST Park
Klosterneuburg, 3400, AT
Beschäftigte von Sarcura
Updates
-
Thrilled to share that Sarcura has won second place at this year's The Deeptech Demo Day 2024! Out of 250 applicants and 10 finalists, our innovative technology stood out. Huge thanks to our CTO, Gerald Kreindl, MBA, for delivering the pitch that represented Sarcura's vision and potential. Looking forward to building on this achievement!
Deeptech SuperAngel VC (Europe pre-seed/seed) | Building Europe's leading Deeptech VC + Community & Sharing live my journey & lessons | Computer Scientist
We have a winner 📢 👇 The Deeptech Demo Day 2024 🥳 ⚛️ Out of 250+ applicants from across Europe >> reviewed by 120+ VC >> 11 deeptech finalists impacting medicine, computing, robotics, climate, space, defence and more! It was such a close battle! With the 2 runner ups coming up in a tie. And VCs already busy reaching out via our platform to ALL of the finalists ─with 40+ intros already solicited last night, and more piling up this morning! Congrats to the 2 x 2nds, of course: 🥈🥈 Sarcura (Daniela Buchmayr: By utilising silicon chip technology, Sarcura is powering new possibilities in cell therapy manufacturing, increasing scalability 100-fold and cutting costs by 10x to make life-saving treatments widely available. And: Glyconix (Marcos Burger Ramos, Sophie James): Leveraging ML algorithms to turn a Nobel Prize winning research tool into immunotherapy-enabling oncology drugs. But for 2024, the winner, is.... Finchetto (Mark Rushworth) 👑 Developing the world's first fully-optical, passive network switch for extreme performance in HPC and AI. --- Thanks to the 4 judges: Max Bautin (co-founder and managing partner at IQ Capital), Julia Hawkins (General Partner at LocalGlobe), Camilla Dolan (General Partner at Eka Ventures), and Michael Bjørnlund (Managing Partner at Rockstart) --- Congrats also to the other finalists too, of course, who have equally won the hearts of investors and are also being asked for intros via our platform! 👏 👏 👏 In no specific order: Xterna (Jessica Corry) 🧬 TissueLabs (Felipe chippari, Gabriel Liguori, MD, PhD) 🔬 Stars Edge (Sara Alão) 🚀 HHC medical (Niels Clausen) 🧪 SpiNNcloud Systems GmbH (Christian Eichhorn) 🛜 Energy Robotics (Marc Dassler) 🤖 Nanusens (Pau Fernandez Guirao, Dr. Josep Montanyà i Silvestre) 🖥️ Allos AI (Aditya Varna Iyer) ⚛️ --- I'm now back wearing the investor hat and will definitely be speaking to these amazing founders, as well as to many from our community who didn't make the finals for just a few points! --- Yes, the quality this year was THAT high!! --- AND IF YOU DID NOT MANAGE TO JOIN BUT WANT TO ALSO CONNECT TO THE FINALISTS 👇 Drop me a comment below and I'll DM you the link to access their decks and request an intro. ---- Thanks Dr Cristina Esteban Pardo & Frontier Deep Tech, my partner in crime for making this possible. And thanks to Mishcon de Reya LLP, OVHcloud and HSBC Innovation Banking for sponsoring and supporting! See you in 2025!
-
-
Excited to share that Sarcura has been selected as a finalist for The Deeptech Demo Day 2024. With over 250+ deep tech startups from across Europe competing this year, and thanks to the expertise of 120+ VC partners involved in scoring, we’re proud to be among the top 10 finalists. Heading into Demo Day – we’re excited to showcase how Sarcura is driving a future where affordable, mass-customized cell therapies become reality, making life-saving treatments accessible to all eligible patients.
🚀 And the FINALISTS of The Deeptech Demo Day 2024 edition are here! This year was so competitive that startups 10th and 11th scored the same. In no particular order: Finchetto (Mark Rushworth): Developing the world's first fully-optical, passive network switch for extreme performance in HPC and AI. TissueLabs (Felipe chippari and Gabriel Liguori, MD, PhD): The platform for creating tissues and organs in the lab. HHC medical (Niels Clausen): Revolutionising gene therapy delivered with wireless electroporation. SpiNNcloud Systems GmbH (Christian Eichhorn): Next-gen computing hardware accelerating hybrid, event driven large AI models. Energy Robotics (Marc Dassler): AI-powered platform for hardware agnostic autonomous robot operations. Stars Edge (Sara Alão) : Making satellites airborne through novel air-breathing electrical propulsion systems -capable of operating with better imaging, connectivity and speed in the upper atmosphere. Xterna (Jessica Corry): RNA targeting using next generation XNAs, focusing on making the untreatable, curable. Glyconix (Marcos Burger Ramos): Leveraging ML algorithms to turn a Nobel Prize winning research tool into immunotherapy-enabling oncology drugs. Nanusens (Pau Fernandez Guirao): Revolutionizing the MEMS semiconductor industry. Allos AI (Aditya Varna Iyer): Allos is an AI native pharma company developing complex generic drugs. Sarcura (Daniela Buchmayr: By utilising silicon chip technology, Sarcura is powering new possibilities in cell therapy manufacturing, increasing scalability 100-fold and cutting costs by 10x to make life-saving treatments widely available. 🎤 Join us on the 7th of Nov to see them pitch live! Our judges: Michael Bjørnlund (Managing Partner (Emerging Technologies) at Rockstart), Julia Hawkins (General Partner at LocalGlobe), Camilla Dolan (General Partner at Eka Ventures), and Max Bautin (co-founder and managing partner at IQ Capital) Who will decide who is the ultimate winner of this edition! ....
-
-
We’re proud to be recognized alongside other leading Austrian biotech startups, all driving innovation in healthcare and reshaping the future of medicine. Austria's thriving biotech ecosystem is laying the groundwork for significant advances in global healthcare. We’re excited to be part of this journey, working towards improving patient outcomes and expanding access to critical treatments. At Sarcura we are powering new possibilities in cell therapy manufacturing—paving the way for scalable and accessible therapies
📈💡Austrian Biotech Innovators With Austria’s biotech ecosystem continually evolving, its contribution to global healthcare is set to grow exponentially. From breakthrough therapies to cutting-edge diagnostics, early-stage startups are pushing the boundaries of what’s possible. Backed by a robust ecosystem of academia, government, and industry collaboration, these innovators are setting the stage for the next big leap in healthcare. But it’s not just about invention—it’s about impact. These startups are tackling some of the world’s most pressing health challenges, striving to cut costs, improve patient outcomes, and expand treatment access on a global scale. 🔗 Read more about the Top 10 Early-Stage Life Sciences/Biotech Startups reshaping the future: https://lnkd.in/gF4pibuy ✨ Featured Startups: ◾ Sarcura – Daniela Buchmayr, Erwin Gorjup (Cell therapy manufacturing) ◾ HeartBeat.bio AG – Michael Krebs, Florian Fuchs (Cardiac drug discovery) ◾ a:head bio AG – Oliver Szolar, Madeline Lancaster (CNS drug discovery) ◾ VALANX Biotech – Michael Lukesch (Protein conjugation) ◾ Cellectric Biosciences – Terje Wimberger, Klemens Wassermann(Precision diagnostics) ◾ Biolyz – Marlon Millard (Non-invasive analytics) ◾ Solgate – Ariel Bensimon, Giulio Superti-Furga, Stefan Kubicek, and Georg Winter (Metabolic disease targeting) ◾ HD Immune – Stefan Bartl, Lionel Wightman (Huntington’s treatment) ◾ Phoenestra GmbH – Klaus Graumann(Cell therapy bioprocessing) ◾ Luminous Labs – Barbara Sekulovska, Thomas Lechner (Red light therapy) ✨ Key Investors Supporting BioTech Innovation: XYZ Ventures | xista science ventures | Nina Capital |CTI Life Sciences Fund | Tensor Ventures | Atrinum. Ventures AG | Austria Wirtschaftsservice | Austrian Angel Investor Association (aaia) 🔍 Explore more such startups on Zefyron's Startup and Investor Database : bit.ly/Zefyron 🆓 Sign up for FREE: bit.ly/ZefyronFree #BiotechInnovation #LifeSciences #Healthcare #AustrianStartups
-
We’re excited that Sarcura will be featured on the Startup Stage at the 2024 BioTools Innovator Capstone event in Boston.
I will be presenting Sarcura on the Startup Stage at the BioTools Innovator 2024 Capstone event in Boston! This event is held in collaboration with BioProcess International. Join us on September 26, 2024, at 10:45 AM in Room 210 of the Exhibit Hall. We look forward to engaging with industry peers and thought leaders, sharing our vision for how we’re powering new possibilities in cell therapy manufacturing.
-
-
#hiring Are you ready to shape the future of cancer treatment? Join us @Sarcura, a pioneering deep-tech start-up situated at xista science park close to Vienna
-
Forget the Milky Way, we’ve got Pluto and Juno brightening up our office galaxy! 🚀🐕Nothing like a few wagging tails and puppy eyes to boost morale and team spirit. 🐾🐕
Happy National Dog Day! 🐾 I’m incredibly lucky to work at Sarcura that not only supports our professional lives but also recognizes the joy our furry friends bring into our day. Being able to bring my dog to work is such a fantastic perk, making the workday brighter and more enjoyable. #DogDay #PetsAtWork
-
-
We are hiring and look forward to receiving your application: https://lnkd.in/gvJ5W-iN
-
Sarcura has been featured in the latest post from the BioTools Innovator Accelerator. The program, along with the BioTools team, has provided us with essential resources, mentorship, and opportunities to help us achieve our milestones. We look forward to the upcoming annual Capstone event on September 26th in Boston, where we'll meet fellow founders and mentors in person.
Welcome back to another week of #FoundersForum. We hope you are as excited about our next company as we are! Sarcura is on a mission to fit an entire room full of #celltherapy #manufacturing processes into the size of a small suitcase, according to CEO and co-founder Daniela Buchmayr. The company is disrupting the industry through #miniaturization, which is made possible thanks to state-of-the-art semiconductor technology and deployed in its small autonomous devices. Want to see Sarcura compete in the final competition on September 26th in Boston? Secure your seat today! 🔗 https://hubs.ly/Q02KcWDz0 #BTICapstone24 #FoundersForum
-
-
-
-
-
+1
-
-
We are excited to announce that Tom Duensing has joined Sarcura's Advisory Board! Tom brings over 25 years of experience in life science tools and biopharmaceutical firms, offering invaluable expertise across the entire company lifecycle. From pioneering new technologies in startups to steering product development in multinational corporations and successfully navigating acquisitions, Tom's insights will be instrumental in driving Sarcura's growth and innovation. Read more: https://lnkd.in/dCb56dng
-